How much jaundice is acceptable for vaccination?
Generally, vaccines can be administered when bilirubin levels are below 12.9 mg/dl for full-term infants, below 15 mg/dl for premature infants, and below 17.1 μmol/L for adults, provided there are no other abnormalities. If uncertain, it is recommended to consult a doctor in advance. Detailed analysis is as follows:
If infants and young children have physiological jaundice within the aforementioned bilirubin range, are in good spirits, and feeding normally, or if adults develop mild jaundice due to minor triggers with bilirubin levels meeting the criteria and no physical discomfort, vaccination will not cause adverse effects. The vaccine can also effectively stimulate an immune response, so vaccination can proceed as planned.
If bilirubin levels in infants and young children exceed the corresponding range or if jaundice is pathological, or if bilirubin levels in adults are elevated due to underlying diseases and accompanied by physical discomfort, vaccination may increase the body's burden, interfere with vaccine effectiveness, and potentially mask the underlying condition. In such cases, treatment should be given first to normalize bilirubin levels, followed by medical evaluation to confirm no abnormalities before vaccination.
Regardless of age, bilirubin levels should be tested before planned vaccination, and a doctor should comprehensively evaluate overall health status to determine eligibility for vaccination.